Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

Saved in:
Bibliographic Details
Published inJournal of genetics and genomics Vol. 47; no. 2; pp. 119 - 121
Main Authors Liu, Xin, Wang, Xiu-Jie
Format Journal Article
LanguageEnglish
Published China Elsevier Ltd 20.02.2020
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press
Subjects
Amino Acid Sequence
Betacoronavirus - drug effects
Betacoronavirus - enzymology
Coronavirus Infections - drug therapy
Drug Approval
Humans
Models, Molecular
Pandemics
Peptide Hydrolases - metabolism
Pneumonia, Viral - drug therapy
Protease Inhibitors - therapeutic use
Protein Structure, Tertiary
Sequence Analysis, Protein
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ISSN:1673-8527
1673-8527
DOI:10.1016/j.jgg.2020.02.001